Skip to Main Content

Author Details

Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
1986
302
64
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36326756Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients With Advanced-Stage ERBB2-Positive Breast Cancer: A Phase 1 Nonrandomized Clinical Trial.JAMA Oncol2023
37295818Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.J Immunother Cancer2023
37093223A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer.Clin Cancer Res2023
36516051Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Intern Med2023
36516049Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA2023
36516048Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Neurol2023
36516046Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Oncol2023
36516043Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Surg2023
36516044Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Pediatr2023
36516039Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Psychiatry2023
36516037Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Otolaryngol Head Neck Surg2023
36516038Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Dermatol2023
36516036Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Ophthalmol2023
36516027Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Cardiol2023
34846625Breast cancer vaccines for treatment and prevention.Breast Cancer Res Treat2022
36516025Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Health Forum2022
36516024Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.JAMA Netw Open2022
36109084Novel peptide-based vaccine targeting heat shock protein 90 induces effective antitumor immunity in a HER2+ breast cancer murine model.J Immunother Cancer2022
36123012Unexpected Liver and Kidney Pathology in C57BL/6J Mice Fed a High-fat Diet and Given Azoxymethane to Induce Colon Cancer.Comp Med2022
35948756Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer.Sci Rep2022
35294258Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.Sci Transl Med2022
35323857JAMA Oncology-The Year in Review, 2021.JAMA Oncol2022
34987061COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes.Cancer Prev Res (Phila)2022
34537824Multimetric feature selection for analyzing multicategory outcomes of colorectal cancer: random forest and multinomial logistic regression models.Lab Invest2022
34081077Equity and the JAMA Network.JAMA Oncol2021
36218750Equity and the JAMA Network.JAMA Health Forum2021
33764381JAMA Oncology-The Year in Review, 2020.JAMA Oncol2021
33762321Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways.J Immunother Cancer2021
33842408Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.J Cancer Prev2021
35047458Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.J Cancer Prev2021
34500046Therapeutic cancer vaccines revamping: technology advancements and pitfalls.Ann Oncol2021
34526999Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention.Front Immunol2021
34526360Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses.Clin Cancer Res2021
34389617Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer.J Immunother Cancer2021
34531249Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.J Immunother Cancer2021
34012451Differentiation and Regulation of T<sub>H</sub> Cells: A Balancing Act for Cancer Immunotherapy.Front Immunol2021
34312215A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.Clin Cancer Res2021
33976232Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients.NPJ Breast Cancer2021
34081110Equity and the JAMA Network.JAMA Netw Open2021
34081109Equity and the JAMA Network.JAMA Surg2021
34081104Equity and the JAMA Network.JAMA Otolaryngol Head Neck Surg2021
34081100Equity and the JAMA Network.JAMA2021
34081094Equity and the JAMA Network.JAMA Neurol2021
34081093Equity and the JAMA Network.JAMA Cardiol2021
34081088Equity and the JAMA Network.JAMA Pediatr2021
34081089Equity and the JAMA Network.JAMA Psychiatry2021
34081087Equity and the JAMA Network.JAMA Ophthalmol2021
34081081Equity and the JAMA Network.JAMA Dermatol2021
34081078Equity and the JAMA Network.JAMA Intern Med2021
31503278Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer.J Natl Cancer Inst2020
  • 1 - 50 of 302

Recommended Authors

Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
Andrea Schietinger
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Glenda Canderan
University of Virginia
Career Start Year 2003
Number of shared co-authors 0
Minya Pu
University of California
Career Start Year 2003
Number of shared co-authors 2
Gavin P Dunn
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Mark E Smolkin
University of Virginia
Career Start Year 2002
Number of shared co-authors 3
Ningyan Zhang
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 0
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Bartosz Chmielowski
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Career Start Year 1999
Number of shared co-authors 6
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 2
Kimberly A Chianese-Bullock
University of Virginia
Career Start Year 1998
Number of shared co-authors 3
Masaki Terabe
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 2
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 4
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 4
Alan Melcher
The Institute of Cancer Research
Career Start Year 1994
Number of shared co-authors 2
Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 5
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 0
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 3
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 2
Sandra Demaria
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 11
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 7
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 1985
Number of shared co-authors 10
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 8
James M Reuben
The University of Texas MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 5
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 5
Steven A Rosenberg
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 10

Collaborators

Robert O Bonow
Northwestern University Feinberg School of Medicine
Co-authored papers 38
Neil M Bressler
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Co-authored papers 38
Frederick P Rivara
University of Washington.
Co-authored papers 27
Holden T Maecker
Co-authored papers 9
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 8
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Co-authored papers 5
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Co-authored papers 4
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Co-authored papers 4
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
John M Kirkwood
UPMC Hillman Cancer Center
Co-authored papers 4
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 3
Rita Nanda
Co-authored papers 3
Craig L Slingluff
University of Virginia
Co-authored papers 3
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers 3
Patrick J Danaher
NanoString Technologies Inc.
Co-authored papers 3
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Co-authored papers 3
Piper M Treuting
University of Washington
Co-authored papers 3
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 3
Ezra E W Cohen
university of california san diego Health System
Co-authored papers 2
David W Cescon
Princess Margaret Cancer Centre
Co-authored papers 2
Giuseppe Curigliano
University of Milan
Co-authored papers 2
Elad Ziv
Institute for Human Genetics, University of California San Francisco (UCSF)
Co-authored papers 2
Damien Chaussabel
Co-authored papers 2
James N Ingle
Mayo Clinic
Co-authored papers 2
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Vesteinn Thorsson
Institute for Systems Biology
Co-authored papers 2
Judy E Garber
Dana-Farber Cancer Institute
Co-authored papers 2
Sharon J Pitteri
Stanford University
Co-authored papers 2
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 2
Avrum Spira
Boston University School of Medicine
Co-authored papers 2
Release 1.2